7-(2-BUTYN-1-YL)-8-(DIMETHYLAMINO)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2-QUINAZOLINYL)METHYL)-1H-PURINE-2,6-DIONE
UNII KD2UN39QWE
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-(2-butyn-1-yl)-8-(dimethylamino)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KD2UN39QWE.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1646355-34-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H23N7O2 ZKRHXTRPKXIHKJ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-(2-butyn-1-yl)-8-(dimethylamino)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.